224 related articles for article (PubMed ID: 35535424)
1. Inhibition of Src but not Syk causes weak reversal of GPVI-mediated platelet aggregation measured by light transmission aggregometry.
Cheung HYF; Moran LA; Sickmann A; Heemskerk JWM; Garcia Á; Watson SP
Platelets; 2022 Nov; 33(8):1293-1300. PubMed ID: 35535424
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function.
Zheng TJ; Lofurno ER; Melrose AR; Lakshmanan HHS; Pang J; Phillips KG; Fallon ME; Kohs TCL; Ngo ATP; Shatzel JJ; Hinds MT; McCarty OJT; Aslan JE
Am J Physiol Cell Physiol; 2021 May; 320(5):C902-C915. PubMed ID: 33689480
[TBL] [Abstract][Full Text] [Related]
3. Distinct contributions of glycoprotein VI and alpha(2)beta(1) integrin to the induction of platelet protein tyrosine phosphorylation and aggregation.
Kamiguti AS; Theakston RD; Watson SP; Bon C; Laing GD; Zuzel M
Arch Biochem Biophys; 2000 Feb; 374(2):356-62. PubMed ID: 10666318
[TBL] [Abstract][Full Text] [Related]
4. Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling.
Navarro-Núñez L; Pollitt AY; Lowe K; Latif A; Nash GB; Watson SP
Thromb Haemost; 2015 May; 113(5):1109-20. PubMed ID: 25694214
[TBL] [Abstract][Full Text] [Related]
5. GPVI potentiation of platelet activation by thrombin and adhesion molecules independent of Src kinases and Syk.
Hughan SC; Hughes CE; McCarty OJ; Schweighoffer E; Soultanova I; Ware J; Tybulewicz VL; Watson SP
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):422-9. PubMed ID: 17110603
[TBL] [Abstract][Full Text] [Related]
6. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.
Spalton JC; Mori J; Pollitt AY; Hughes CE; Eble JA; Watson SP
J Thromb Haemost; 2009 Jul; 7(7):1192-9. PubMed ID: 19422460
[TBL] [Abstract][Full Text] [Related]
7. RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation.
Jones ML; Harper MT; Aitken EW; Williams CM; Poole AW
J Thromb Haemost; 2010 Mar; 8(3):567-76. PubMed ID: 20002543
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal SH2 domain of Syk is required for (hem)ITAM, but not integrin, signaling in mouse platelets.
Hughes CE; Finney BA; Koentgen F; Lowe KL; Watson SP
Blood; 2015 Jan; 125(1):144-54. PubMed ID: 25352128
[TBL] [Abstract][Full Text] [Related]
9. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
Huang TF; Chang CH; Ho PL; Chung CH
Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
[TBL] [Abstract][Full Text] [Related]
10. C-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in mice.
Yokomori R; Shirai T; Tsukiji N; Oishi S; Sasaki T; Takano K; Suzuki-Inoue K
Platelets; 2023 Dec; 34(1):2281941. PubMed ID: 38010137
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein IIb-IIIa-dependent aggregation by glycoprotein Ibalpha is reinforced by a Src family kinase inhibitor (PP1)-sensitive signalling pathway.
Marshall SJ; Asazuma N; Best D; Wonerow P; Salmon G; Andrews RK; Watson SP
Biochem J; 2002 Jan; 361(Pt 2):297-305. PubMed ID: 11772401
[TBL] [Abstract][Full Text] [Related]
12. Ligand binding rapidly induces disulfide-dependent dimerization of glycoprotein VI on the platelet plasma membrane.
Arthur JF; Shen Y; Kahn ML; Berndt MC; Andrews RK; Gardiner EE
J Biol Chem; 2007 Oct; 282(42):30434-41. PubMed ID: 17690106
[TBL] [Abstract][Full Text] [Related]
13. Micromolar concentrations of citalopram or escitalopram inhibit glycoprotein VI-mediated and integrin αIIbβ3-mediated signaling in human platelets.
Tseng YL; Braun A; Chang JP; Chiang ML; Tseng CY; Chen W
Toxicol Appl Pharmacol; 2019 Feb; 364():106-113. PubMed ID: 30592962
[TBL] [Abstract][Full Text] [Related]
14. Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: involvement of PLCgamma1 and PI3-kinase.
Suzuki-Inoue K; Inoue O; Frampton J; Watson SP
Blood; 2003 Aug; 102(4):1367-73. PubMed ID: 12730118
[TBL] [Abstract][Full Text] [Related]
15. Akt and mitogen-activated protein kinase enhance C-type lectin-like receptor 2-mediated platelet activation by inhibition of glycogen synthase kinase 3α/β.
Moroi AJ; Watson SP
J Thromb Haemost; 2015 Jun; 13(6):1139-50. PubMed ID: 25858425
[TBL] [Abstract][Full Text] [Related]
16. Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology.
Zheng TJ; Parra-Izquierdo I; Reitsma SE; Heinrich MC; Larson MK; Shatzel JJ; Aslan JE; McCarty OJT
Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1231-C1250. PubMed ID: 35938677
[TBL] [Abstract][Full Text] [Related]
17. Differential Regulation of GPVI-Induced Btk and Syk Activation by PKC, PKA and PP2A in Human Platelets.
Zhang P; Solari FA; Heemskerk JWM; Kuijpers MJE; Sickmann A; Walter U; Jurk K
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175486
[TBL] [Abstract][Full Text] [Related]
18. Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.
Manne BK; Badolia R; Dangelmaier C; Eble JA; Ellmeier W; Kahn M; Kunapuli SP
J Biol Chem; 2015 May; 290(18):11557-68. PubMed ID: 25767114
[TBL] [Abstract][Full Text] [Related]
19. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2.
Suzuki-Inoue K; Fuller GL; García A; Eble JA; Pöhlmann S; Inoue O; Gartner TK; Hughan SC; Pearce AC; Laing GD; Theakston RD; Schweighoffer E; Zitzmann N; Morita T; Tybulewicz VL; Ozaki Y; Watson SP
Blood; 2006 Jan; 107(2):542-9. PubMed ID: 16174766
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation on Syk Y342 is important for both ITAM and hemITAM signaling in platelets.
Kostyak JC; Mauri B; Dangelmaier C; Vari HR; Patel A; Wright M; Reddy H; Tsygankov AY; Kunapuli SP
J Biol Chem; 2022 Aug; 298(8):102189. PubMed ID: 35753354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]